发明名称 DIAGNOSIS, PROGNOSIS, AND TREATMENT OF KIDNEY DISEASE
摘要 The present invention relates to the discovery that an increased fraction of albumin is carbamylated in patients suffering from kidney disease (e.g., end-stage renal disease) and that the fraction of carbamylated albumin is also correlated with increased disease severity, particularly risk of mortality. The present invention also relates to the discovery that free amino acids can reduce carbamylation of albumin. Based on these discoveries the present invention provides diagnostic and prognostic methods for patients suffering from, or suspected of suffering from kidney disease. The invention also provides methods for treating kidney disease by administration of a compound or composition that reduced protein carbamylation, such as free amino acids or dipeptides.
申请公布号 US2014228296(A1) 申请公布日期 2014.08.14
申请号 US201214131866 申请日期 2012.07.13
申请人 Berg Anders H.;Karumanchi S. Ananth;Thadhani Ravi I. 发明人 Berg Anders H.;Karumanchi S. Ananth;Thadhani Ravi I.
分类号 A61K38/06;A61K31/4172;A61K31/255;A61K31/145;A61K38/05;A61K31/198 主分类号 A61K38/06
代理机构 代理人
主权项 1. A method for diagnosing kidney disease, determining the likelihood of developing kidney disease, or determining the severity of kidney disease in a subject, said method comprising determining the fraction of carbamylated albumin in said subject, wherein an increased fraction of carbamylation of said albumin, as compared to a control, is indicative of the presence of disease, an increased likelihood of developing disease, or increased disease severity.
地址 Dedham MA US